Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

BACKGROUND: The herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycoprotein E (gE) and AS01(B) Adjuvant System, was highly efficacious in preventing herpes zoster in the ZOE-50 and ZOE-70 trials. We present immunogenicity results from those trials. METHODS: Participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunningham, Anthony L, Heineman, Thomas C, Lal, Himal, Godeaux, Olivier, Chlibek, Roman, Hwang, Shinn-Jang, McElhaney, Janet E, Vesikari, Timo, Andrews, Charles, Choi, Won Suk, Esen, Meral, Ikematsu, Hideyuki, Choma, Martina Kovac, Pauksens, Karlis, Ravault, Stéphanie, Salaun, Bruno, Schwarz, Tino F, Smetana, Jan, Abeele, Carline Vanden, Van den Steen, Peter, Vastiau, Ilse, Weckx, Lily Yin, Levin, Myron J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946839/
https://www.ncbi.nlm.nih.gov/pubmed/29529222
http://dx.doi.org/10.1093/infdis/jiy095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946839/
https://www.ncbi.nlm.nih.gov/pubmed/29529222
http://dx.doi.org/10.1093/infdis/jiy095

Ejemplares similares